Bell Rock Capital’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$1.5M Buy
+15,711
New +$1.56M 1.85% 13
2022
Q2
Sell
-13,753
Closed -$1.44M 48
2022
Q1
$1.44M Sell
13,753
-5,512
-29% -$579K 1.34% 19
2021
Q4
$2.01M Buy
+19,265
New +$1.78M 1.48% 17
2020
Q1
Sell
-2,763
Closed -$205K 112
2019
Q4
$205K Buy
2,763
+367
+15% +$25.8K 0.18% 110
2019
Q3
$151K Buy
2,396
+1,607
+204% +$95.2K 0.13% 119
2019
Q2
$43K Buy
789
+354
+81% +$19.1K 0.04% 215
2019
Q1
$23K Buy
435
+3
+0.7% +$185 0.01% 287
2018
Q4
$28K Buy
432
+382
+764% +$28.5K 0.02% 271
2018
Q3
$4K Sell
50
-200
-80% -$14.3K ﹤0.01% 388
2018
Q2
$16K Sell
250
-90
-26% -$5.93K 0.01% 345
2018
Q1
$21K Sell
340
-745
-69% -$53.5K 0.01% 319
2017
Q4
$79K Sell
1,085
-5,485
-83% -$399K 0.04% 204
2017
Q3
$534K Sell
6,570
-4,372
-40% -$346K 0.3% 70
2017
Q2
$882K Buy
+10,942
New +$864K 0.54% 55

Other funds holding CVS

Bell Rock Capital's CVS Position: Q3 2022 in Review

Bell Rock Capital opened a new position in CVS Health (CVS) in Q3 2022: 15,711 shares worth $1.5M. The stake represents 1.85% of the portfolio and ranks #13 among its holdings. This is a return to the name: Bell Rock Capital previously reported a position in CVS as recently as Q1 2022.

Bell Rock Capital first reported a position in CVS in Q2 2017 and has held it in 14 quarters since. The position peaked at $2.01M in Q4 2021. 2,324 funds tracked by Wall St. Rank hold CVS as of Q3 2022.

  • Bell Rock Capital held 15,711 shares of CVS Health worth $1.5M as of Q3 2022.
  • CVS Health was a new Bell Rock Capital position in Q3 2022.
  • CVS Health made up 1.85% of Bell Rock Capital's portfolio in Q3 2022, its #13 holding.
  • Bell Rock Capital first reported a position in CVS Health in Q2 2017 and has held it in 14 quarters since.
  • Bell Rock Capital's CVS Health position peaked at $2.01M in Q4 2021.
  • 2,324 funds tracked by Wall St. Rank held CVS Health as of Q3 2022.

Based on Bell Rock Capital's 13F filing for Q3 2022, filed 28 Oct 2022.